Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.12% | 200.81 | 1.2% | $402.10m | |
| GILD | Gilead Sciences, Inc. | 0.01% | 72.79 | 0.9% | $394.52m | |
| CELG | Celgene Corporation | 0.18% | 87.36 | 1.2% | $339.76m | |
| BIIB | Biogen Inc. | -1.26% | 334.40 | 1.2% | $273.97m | |
| ILMN | Illumina, Inc. | -1.67% | 347.22 | 3.5% | $252.24m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.45% | 386.49 | 2.6% | $210.24m | |
| EXAS | Exact Sciences Corporation | 0.00% | 73.33 | 25.3% | $198.68m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.79% | 175.80 | 1.9% | $159.87m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.27% | 152.35 | 16.4% | $124.87m | |
| A | Agilent Technologies, Inc. | 0.33% | 69.08 | 1.5% | $121.49m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.33% | 117.81 | 2.0% | $107.50m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -3.90% | 93.35 | 9.7% | $95.81m | |
| NKTR | Nektar Therapeutics | -1.48% | 57.45 | 5.6% | $94.55m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.27% | 98.15 | 4.4% | $90.68m | |
| INCY | Incyte Corporation | -1.57% | 67.02 | 2.5% | $87.71m |
Company Profile
SELLAS Life Sciences Group, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the development and commercialization of novel cancer immunotherapeutic for a broad range of indications. Its product galinpepimut-S, or GPS, is an immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, which targets the Wilms tumor 1, or WT1, protein. The company was founded on April 3, 2006 and is headquartered in New York, NY.